Literature DB >> 31417667

Lowering Lipophilicity by Adding Carbon: AzaSpiroHeptanes, a logD Lowering Twist.

Sébastien L Degorce1, Michael S Bodnarchuk1, James S Scott1.   

Abstract

We have conducted an analysis of azaspiro[3.3]heptanes used as replacements for morpholines, piperidines, and piperazines in a medicinal chemistry context. In most cases, introducing a spirocyclic center lowered the measured logD 7.4 of the corresponding molecules by as much as -1.0 relative to the more usual heterocycle. This may seem counterintuitive, as the net change in the molecule is the addition of a single carbon atom, but it may be rationalized in terms of increased basicity. An exception to this was found with N-linked 2-azaspiro[3.3]heptane, where logD 7.4 increased by as much as +0.5, consistent with the addition of carbon. During our investigation, we also concluded that azaspiro[3.3]heptanes are most likely not suitable bioisosteres for morpholines, piperidines, and piperazines, when not used as terminal groups, due to significant changes in their geometry.

Entities:  

Year:  2019        PMID: 31417667      PMCID: PMC6693472          DOI: 10.1021/acsmedchemlett.9b00248

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  27 in total

1.  Estrogen receptor ligands. Part 7: Dihydrobenzoxathiin SERAMs with bicyclic amine side chains.

Authors:  Timothy A Blizzard; Frank DiNinno; Jerry D Morgan; Helen Y Chen; Jane Y Wu; Candido Gude; Seongkon Kim; Wanda Chan; Elizabeth T Birzin; Yi Tien Yang; Lee-Yuh Pai; Zhoupeng Zhang; Edward C Hayes; Carolyn A DaSilva; Wei Tang; Susan P Rohrer; James M Schaeffer; Milton L Hammond
Journal:  Bioorg Med Chem Lett       Date:  2004-08-02       Impact factor: 2.823

2.  Synthesis of azaspirocycles and their evaluation in drug discovery.

Authors:  Johannes A Burkhard; Björn Wagner; Holger Fischer; Franz Schuler; Klaus Müller; Erick M Carreira
Journal:  Angew Chem Int Ed Engl       Date:  2010-05-03       Impact factor: 15.336

3.  Identification of potent and selective cathepsin S inhibitors containing different central cyclic scaffolds.

Authors:  Hans Hilpert; Harald Mauser; Roland Humm; Lilli Anselm; Holger Kuehne; Guido Hartmann; Sabine Gruener; David W Banner; Joerg Benz; Bernard Gsell; Andreas Kuglstatter; Martine Stihle; Ralf Thoma; Rubén Alvarez Sanchez; Hans Iding; Beat Wirz; Wolfgang Haap
Journal:  J Med Chem       Date:  2013-11-22       Impact factor: 7.446

4.  Spirocyclic oxetanes: synthesis and properties.

Authors:  Georg Wuitschik; Mark Rogers-Evans; Andreas Buckl; Maurizio Bernasconi; Moritz Märki; Thierry Godel; Holger Fischer; Björn Wagner; Isabelle Parrilla; Franz Schuler; Josef Schneider; André Alker; W Bernd Schweizer; Klaus Müller; Erick M Carreira
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

5.  Towards the next generation of dual Bcl-2/Bcl-xL inhibitors.

Authors:  Jeffrey G Varnes; Thomas Gero; Shan Huang; R Bruce Diebold; Claude Ogoe; Paul T Grover; Mei Su; Prasenjit Mukherjee; Jamal Carlos Saeh; Terry MacIntyre; Galina Repik; Keith Dillman; Kate Byth; Daniel John Russell; Stephanos Ioannidis
Journal:  Bioorg Med Chem Lett       Date:  2014-05-20       Impact factor: 2.823

6.  Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series.

Authors:  Nicolas Lachance; Yves Gareau; Sébastien Guiral; Zheng Huang; Elise Isabel; Jean-Philippe Leclerc; Serge Léger; Evelyn Martins; Christian Nadeau; Renata M Oballa; Stéphane G Ouellet; David A Powell; Yeeman K Ramtohul; Geoffrey K Tranmer; Thao Trinh; Hao Wang; Lei Zhang
Journal:  Bioorg Med Chem Lett       Date:  2011-12-08       Impact factor: 2.823

7.  Use of small-molecule crystal structures to address solubility in a novel series of G protein coupled receptor 119 agonists: optimization of a lead and in vivo evaluation.

Authors:  James S Scott; Alan M Birch; Katy J Brocklehurst; Anders Broo; Hayley S Brown; Roger J Butlin; David S Clarke; Ojvind Davidsson; Anne Ertan; Kristin Goldberg; Sam D Groombridge; Julian A Hudson; David Laber; Andrew G Leach; Philip A Macfaul; Darren McKerrecher; Adrian Pickup; Paul Schofield; Per H Svensson; Pernilla Sörme; Joanne Teague
Journal:  J Med Chem       Date:  2012-05-17       Impact factor: 7.446

8.  A high throughput dried DMSO LogD lipophilicity measurement based on 96-well shake-flask and atmospheric pressure photoionization mass spectrometry detection.

Authors:  Yun W Alelyunas; Luciana Pelosi-Kilby; Pascal Turcotte; Mary-Britt Kary; Russell C Spreen
Journal:  J Chromatogr A       Date:  2010-01-29       Impact factor: 4.759

9.  Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase.

Authors:  John M Keith; William M Jones; Joan M Pierce; Mark Seierstad; James A Palmer; Michael Webb; Mark J Karbarz; Brian P Scott; Sandy J Wilson; Lin Luo; Michelle L Wennerholm; Leon Chang; Sean M Brown; Michele Rizzolio; Raymond Rynberg; Sandra R Chaplan; J Guy Breitenbucher
Journal:  Bioorg Med Chem Lett       Date:  2014-01-06       Impact factor: 2.823

10.  Four-membered heterocycles-containing 4-anilino-quinazoline derivatives as epidermal growth factor receptor (EGFR) kinase inhibitors.

Authors:  Feng Zhao; Zhaohu Lin; Feng Wang; Weili Zhao; Xiaochun Dong
Journal:  Bioorg Med Chem Lett       Date:  2013-07-31       Impact factor: 2.823

View more
  2 in total

1.  The N,N,O-Trisubstituted Hydroxylamine Isostere and Its Influence on Lipophilicity and Related Parameters.

Authors:  Jarvis Hill; David Crich
Journal:  ACS Med Chem Lett       Date:  2022-04-20       Impact factor: 4.632

2.  Turning the Other Cheek: Influence of the cis-Tetrafluorocyclohexyl Motif on Physicochemical and Metabolic Properties.

Authors:  Yong Wang; Wendy Lee; Yi-Chen Chen; Yuhui Zhou; Emile Plise; Madyson Migliozzi; James J Crawford
Journal:  ACS Med Chem Lett       Date:  2022-08-14       Impact factor: 4.632

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.